Skip to main content

Advertisement

SpringerLink
Log in

IgG4 deposits in pure and combined membranous lupus nephritis

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study is to determine the frequency and prognosis of IgG4 deposits in renal biopsy of patients with membranous lupus nephritis (MLN). This is a retrospective cohort study in which we included patients with class V alone or combined (III/V or IV/V) of lupus nephritis according to the 2004 ISN/RPS. All the patients included must have availability of renal tissue for immunohistochemistry analyses. We excluded other classes of lupus nephritis. The renal tissue was examined by a nephro-pathologist. We included 65 patients with MLN; of these, 24 (37 %) were class V, and the other had proliferative concomitant with membranous patterns. Seven renal specimens had IgG4 deposits (10 %). Patients with IgG4 deposits had higher levels of eosinophils in serum. All of the patients with IgG4 had renal involvement as first manifestations of systemic lupus erythematosus. The rate of renal failure was 42 and 43 % in IgG4 positive and negative, respectively, 28 % of IgG4 required renal replacement therapy. From a histological view, 42 % of IgG4 had evidence of arteriolar vasculitis in renal biopsies. Lupus patients with IgG4 deposits were more likely to have renal involvement as a first manifestation of systemic lupus erythematosus, and they course with a worse prognosis since they required more dialysis. Also, they have more probability of vascular inflammation on the renal biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Mok CC, Kwok RCL, Yip PSF (2013) Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum 65:2154–2160. doi:10.1002/art.38006

    Article  CAS  PubMed  Google Scholar 

  2. Lee LYW, Yap H, Sampson S et al (2014) IgG4- related disease as a rare cause of tubulointerstitial nephritis. J Clin Immunol 34:548–550. doi:10.1007/s10875-014-0049-9

    Article  CAS  PubMed  Google Scholar 

  3. Imai H, Hamai K, Komatsuda A et al (1997) IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 51:270–276

    Article  CAS  PubMed  Google Scholar 

  4. Yahata M, Takahashi S, Nakaya I et al (2012) Possible IgG4-related kidney disease requiring a differential diagnosis of membranous lupus nephritis. Intern Med 51:1731–1736

    Article  PubMed  Google Scholar 

  5. Satoskar AA, Brodsky SV, Nadasdy G et al (2011) Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis. Lupus 20:1396–1403. doi:10.1177/0961203311416533

    Article  CAS  PubMed  Google Scholar 

  6. Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250

    Article  PubMed  Google Scholar 

  7. Desai N, Cimbaluk D, Lewis EJ, Whittier WL (2013) Proteinuria in membranous lupus nephritis: the pathology is in the podocyte. Lupus 22:461–468. doi:10.1177/0961203313477225

    Article  CAS  PubMed  Google Scholar 

  8. Alexander MP, Larsen CP, Gibson IW et al (2013) Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 83:455–462. doi:10.1038/ki.2012.382

    Article  CAS  PubMed  Google Scholar 

  9. Filippone EJ (2013) Immunosuppressive treatment of idiopathic membranous nephropathy: the dilemma continues. Clin Nephrol 79:143–153. doi:10.5414/CN107743

    Article  CAS  PubMed  Google Scholar 

  10. Ronco P, Debiec H (2012) Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol 8:203–213. doi:10.1038/nrneph.2012.35

    Article  CAS  PubMed  Google Scholar 

  11. Ebbo M, Daniel L, Pavic M et al (2012) IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) 91:49–56. doi:10.1097/MD.0b013e3182433d77

    Article  CAS  Google Scholar 

  12. Khosroshahi A, Wallace ZS, Crowe JL et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. doi:10.1002/art.39132

    PubMed  Google Scholar 

  13. Zhang H, Li P, Wu D et al (2015) Serum IgG subclasses in autoimmune diseases. Medicine (Baltimore) 94:e387. doi:10.1097/MD.0000000000000387

    Article  CAS  Google Scholar 

  14. Abdellatif AA, Waris S, Lakhani A et al (2010) True vasculitis in lupus nephritis. Clin Nephrol 74:106–112

    Article  CAS  PubMed  Google Scholar 

  15. Wu L-H, Yu F, Tan Y et al (2013) Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83:715–723. doi:10.1038/ki.2012.409

    Article  CAS  PubMed  Google Scholar 

  16. Barber C, Herzenberg A, Aghdassi E et al (2012) Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol 7:757–764. doi:10.2215/CJN.02870311

    Article  PubMed  PubMed Central  Google Scholar 

  17. Perez Alamino R, Martínez C, Espinoza LR (2013) IgG4-associated vasculitis. Curr Rheumatol Rep 15:348. doi:10.1007/s11926-013-0348-9

    Article  PubMed  Google Scholar 

  18. Perez Alamino R, Espinoza LR, Zea AH (2013) The great mimicker: IgG4-related disease. Clin Rheumatol 32:1267–1273. doi:10.1007/s10067-013-2326-z

    Article  PubMed  Google Scholar 

  19. Pradhan D, Pattnaik N, Silowash R, Mohanty SK (2015) IgG4-related kidney disease—a review. Pathol Res Pract 211:707–711. doi:10.1016/j.prp.2015.03.004

    Article  CAS  PubMed  Google Scholar 

  20. Raissian Y, Nasr SH, Larsen CP et al (2011) Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22:1343–1352. doi:10.1681/ASN.2011010062

    Article  PubMed  PubMed Central  Google Scholar 

  21. Jefferson JA, Pippin JW, Shankland SJ (2010) Experimental models of membranous nephropathy. Drug Discov Today Dis Models 7:27–33. doi:10.1016/j.ddmod.2010.11.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Shimizu S, Sugiyama N, Masutani K et al (2005) Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 175:7185–7192

    Article  CAS  PubMed  Google Scholar 

  23. Stone JH (2011) IgG4 related disease. N Engl J Med 366:539–551. doi:10.1016/j.lpm.2011.10.016

    Article  Google Scholar 

  24. Kuroki A, Shibata T, Honda H et al (2002) Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41:936–942

    Article  CAS  PubMed  Google Scholar 

  25. Beck LH, Bonegio RGB, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21. doi:10.1056/NEJMoa0810457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Donadio JV, Burgess JH, Holley KE (1977) Membranous lupus nephropathy: a clinicopathologic study. Medicine (Baltimore) 56:527–536

    Article  Google Scholar 

  27. do Nascimento AP, Viana VST, Testagrossa L de A et al (2006) Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 54:1568–1572. doi:10.1002/art.21875

    Article  PubMed  Google Scholar 

  28. Vlahakos DV, Foster MH, Adams S et al (1992) Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 41:1690–1700

    Article  CAS  PubMed  Google Scholar 

  29. Vlahakos D, Foster MH, Ucci AA et al (1992) Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 2:1345–1354

    CAS  PubMed  Google Scholar 

  30. Mason LJ, Ravirajan CT, Rahman A et al (2004) Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum 50:866–870. doi:10.1002/art.20103

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Reumatología y Patología, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Venustiano Carranza 2395, Zona Universitaria, San Luis, Mexico

    David Herrera van Oostdam, Marco U. Martínez Martínez, Cuauhtémoc Oros-Ovalle, David Martínez-Gala, Gerardo T. Jaimes Piñón & Carlos Abud Mendoza

Authors
  1. David Herrera van Oostdam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco U. Martínez Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cuauhtémoc Oros-Ovalle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Martínez-Gala
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gerardo T. Jaimes Piñón
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carlos Abud Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos Abud Mendoza.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herrera van Oostdam, D., Martínez Martínez, M.U., Oros-Ovalle, C. et al. IgG4 deposits in pure and combined membranous lupus nephritis. Clin Rheumatol 35, 1619–1623 (2016). https://doi.org/10.1007/s10067-016-3276-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3276-z

Keywords

Search

Navigation